Lv4
562 积分 2024-08-14 加入
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
12小时前
待确认
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
12小时前
待确认
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
13小时前
待确认
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
14小时前
待确认
Benralizumab for the Prevention of COPD Exacerbations
15小时前
待确认
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
15小时前
待确认
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
15小时前
待确认
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
16小时前
待确认
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
21小时前
待确认
[Effectiveness and safety of replacement treatment with the growth hormone drug Saizen in a new formulation]
29天前
已关闭
皖公网安备34019202002308
